SVFC DUE DILIGENCE !! The transfer
Post# of 131
The transfer agent for the company is Continental and the float is approximately 27M . There are 500M authorized shares and the outstanding shares after full dilution is upwards of 150M with 39M in warrants.
CONTACT :
info@intellicellbiosciences.com
arhodes@intellicellbiosciences.com
Svictor@intellicellbiosciences.com
T: 646.576.8710
C: 917.209.6636
F: 212.249.1482
INTELLICELL BIOSCIENCES Management has identified a number of acquisitions which could be negotiated that might be helpful to IntelliCell BioSciences in moving forward rapidly and solidifying its position as the technology leader in the Regenerative Medicine field in the United States and abroad
... Intellicell Biosciences are in Discussions with MAJOR PHARMA's and Generic Pharmaceuticals about various Partnerships and Licensing Arrangements for many of INTELLICELLS key Products!!!...IN USA...and ABROAD !!...
..In addition to Millipore Corporation , which now has an agreement with IntelliCell BioSciences, management and its representatives have been in discussion with other major pharmas and generic pharmaceutical companies about various partnerships and licensing arrangements for many of IntelliCell’s key products, both in the United States and overseas [/b] .[/quote][/b]